Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
Sci. Signal., 7 July 2009 EDITORS' CHOICE
>
Microbiology Breaking the BarrierStella M. Hurtley Science, AAAS, Cambridge, CB2 1LQ UK
Being able to deliver drugs into the brain to treat degenerative diseases such as Alzheimer or Parkinson diseases requires the ability to traverse the blood brain barrier (BBB). Understanding the formation of the very specific adherent junctions (AJ) and tight junctions present at the BBB cell junctions is a prerequisite to the design of such therapeutics. However, diminishing the expression of any one component involved in the formation of these intercellular junctions destroys them. Coureuil et al. exploited the specific recruitment of AJ proteins by Neisseria meningitidis to dissect this process. Adhesion of the bacteria to human brain endothelial cells recruited the polarity complex Par3-Par6-PKC M. Coureuil, G. Mikaty, F. Miller, H. Lécuyer, C. Bernard, S. Bourdoulous, G. Duménil, R.-M. Mège, B. B. Weksler, I. A. Romero, P.-O. Couraud, X. Nassif, Meningococcal type IV pili recruit the polarity complex to cross the brain endothelium. Science 325, 83–87 (2009).[Abstract] [Full Text]
Citation: S. M. Hurtley, Breaking the Barrier. Sci. Signal. 2, ec229 (2009). The editors suggest the following Related Resources on Science sites:In Science Signaling
|
Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882